baber/WOPTO huggingface dataset:
Patent CA-3037641-A1 (CA)
Inventor: DWYER BONNIE
IPC: G08B5/02
Filed: 2019-03-22
Abstract: A service indication device that is operable to provide a user a technique to signal a wait staff personnel that either service is required or not required.  The service indication device includes a body wherein the body is planar in manner. The body includes a first side and a second side. The body has a perimeter edge that defines the shape thereof. The first side of the body has a surface area wherein the surface area has a first color disposed thereon. The second side of the body includes a surface area that has a second color disposed thereon. The first color is utilized to indicate a need for service. The second side and as such the second color is displayed by a user to indicate that there is no need for service. The preferred shape for the body is a plus sign.
Patent CA-3038556-A1 (CA)
Title: Composition useful in sulfate scale removal
Inventor: PURDY CLAY
IPC: E21B37/06
Filed: 2019-04-01
Abstract: The present invention discloses a novel aqueous composition for use in removing petroleum-contaminated barium sulfate scale from a surface contaminated with such, said composition comprising: a chelating agent and a counterion component selected from the group consisting of: Li5DTPA;  Na5DTPA; K5DTPA; Cs5DTPA; Na4EDTA; K4EDTA; TEAR4DTPA; and TBAH5DTPA; a scale removal enhancer; and a non-ionic surfactant. There is also disclosed methods to use such compositions.
Patent CA-3039169-A1 (CA)
Title: Photochromatic modulation with fluorescein for the treatment of photo-oculodynia and blepharospasm
Inventor: YEN MICHAEL TZE-CHIEN
IPC: C12Q1/68
Filed: 2017-09-22
Abstract: Embodiments of the disclosure concern methods and compositions that include a substrate that comprises at least one fluorophore in sufficient amounts and delivery of the substrate to an individual in need of treatment. In specific embodiments, a sufficient amount of fluorescein is provided on a contact lens, for example, and delivered to an individual suffering from blepharospasm.
Patent CA-3041432-A1 (CA)
Inventor: WANG BAOLIN
IPC: C07D211/60
Filed: 2018-03-02
Abstract: The present invention provides an improved method for the preparation of 5R-benzyloxyaminopiperidine-2S-formate and an oxalate thereof. The present invention uses L-glutamic acid or L-glutamic acid sodium salt as a starting material, and prepares a compound III by a substitution reaction with chloroacetic acid under basic conditions; reacting the compound III with an alcohol for an esterification reaction in the presence of an acidic reagent, to obtain compound IV; intramolecularly condensing compound IV into a ring and hydrolytically decarboxylating and esterification of the same under the action of a strong base to obtain compound V; condensing compound V with benzyloxyamine hydrochloride in the presence of a base to obtain compound VI; and reducing and chirally separating compound VI to obtain 5R-benzyloxyaminopiperidine-2S-formate oxalate, and neutralizing the compound IIb to give 5R-benzyloxyaminopiperidine-2S-formate. The 5R-benzyloxyaminopiperidine-2S-formate or 5R-benzyloxyaminopiperidine-2S-formate oxalate is useful in the preparation of avibactam. The present invention uses cheap and easily available raw materials, has high reaction selectivity, and has an environmentally-friendly production process.
Patent CA-3043189-A1 (CA)
Inventor: LANGENFELD CHRISTOPHER C
IPC: C12M3/00
Filed: 2017-11-07
Abstract: L'invention concerne un système et un procédé de culture et de maintien de matériel biologique comprenant la production d'une protéine associée au tissu, la sélection des cellules associées au tissu, la multiplication des cellules, la création d'au moins une bio-encre tissulaire comprenant les cellules multipliées, l'impression de ladite ou desdites bio-encres tissulaires dans au moins un mélange de milieu de croissance tissulaire, la croissance du tissu à partir de la ou des bio-encres tissulaires imprimées, et le maintien de la viabilité du tissu.
Patent CA-3044273-A1 (CA)
Inventor: BEAUMONT DARCY L
IPC: F16L21/06
Filed: 2019-05-27
Abstract: An advanced coupling system that mechanically joins pipe elements together in an end to end configuration. The advanced coupling system interfaces with other coupling makes and models. The advanced coupling system can be fitted with spacers, deflection cones, orifice plates, check valves and protective pipe liners which are positioned between the inside faces of the piping elements with or without stiffening rings.  Stiffening rings are fitted with optional access ports to accommodate wires, sensors and probes to monitor pressure, temperature, erosion and corrosion within piping systems.  Installation of the protective pipe liners is dramatically improved with the use of an alignment tool and cradle.  Installation of the coupling segments is dramatically improved with the use of hinges.
Patent CA-3044681-A1 (CA)
Inventor: NGUYEN PETER
IPC: A61K9/107
Filed: 2017-12-19
Abstract: L'invention concerne des procédés et des techniques destinés à émulsifier des composés non polaires, tels que des acides gras oméga. L'invention concerne également des compositions qui peuvent être préparées selon les procédés et les techniques décrits dans la description. Les compositions, par exemple, comportent une quantité élevée de composé non polaire, telle qu'une quantité importante d'acides gras oméga. Les composés non polaires sont également présents dans de très petites gouttelettes au sein de la composition. Par exemple, la taille de particule moyenne ou médiane des gouttelettes est inférieure à environ 5 µm. En outre, la composition comprend une faible quantité de tensioactif, telle qu'inférieure à environ 10 à 15 % du tensioactif.
Patent CA-3044769-A1 (CA)
Title: Compositions comprising fluoroolefins and uses thereof
Inventor: LECK THOMAS J
IPC: F25B27/00
Filed: 2006-10-31
Abstract: The present invention relates to methods for producing heating or cooling in a refrigeration, air-conditioning, or heat pump apparatus by introducing refrigerant or heat transfer fluoroolefin compositions into the apparatus. The fluoroolefin compositions of the present invention are useful as refrigerants or heat transfer fluids and in processes for producing cooling or heat. Additionally, the fluoroolefin compositions of the present invention may be used to replace currently used refrigerant or heat transfer fluid compositions that have higher global warming potential.
Patent CA-3046774-A1 (CA)
Inventor: KING DAVID WILLIAM
IPC: G06Q20/32
Filed: 2019-06-14
Abstract: Disclosed herein are multispace parking pay stations comprising: a processor, a memory, a communications element, a printer, and a computer program including instructions executable by the processor to create an application comprising: a software module receiving a unique identifier associated with a parking customer, the parking customer having executed a mobile payment for parking in a space associated with the pay station; a software module transmitting the unique identifier to a central parking management server and querying the central parking management server with the unique identifier to identify the parking customer and verify the mobile payment; and a software module generating and sending instructions to the printer to print a payment verification for the parking customer.
Patent CA-3047136-A1 (CA)
Title: Inhibiteurs d'isocitrate deshydrogenases mutantes, compositions et procedes correspondants
Inventor: ZHANG TINGHU
IPC: C07D413/14
Filed: 2017-12-18
Abstract: L'invention concerne de nouveaux composés chimiques utiles pour traiter le cancer, ou une maladie ou un trouble associé au cancer, ainsi qu'une composition pharmaceutique contenant ces composés, et des procédés de préparation et d'utilisation de ceux-ci.
Patent CA-3048602-A1 (CA)
Inventor: MAKITA KEIKO
IPC: A61P35/00
Filed: 2017-12-27
Abstract: The present invention addresses the problem of providing an antitumor agent that is exceptional as a treatment agent for the prevention and/or treatment of tumors involving bromodomains, and providing a bromodomain inhibitor that is useful as a treatment agent for diseases or conditions involving bromodomains. An antitumor agent and bromodomain inhibitor containing a compound represented by the general formula [in the formula, R1 represents a C1-6 alkyl group, etc.; R2 represents a hydrogen atom, etc.; R3 represents a halogen atom, etc.; Z1, Z2, and Z3 represent CH, etc.; X1 represents CONH, etc.; ring A represents a phenyl group, etc.; R4 represents a halogen atom, etc.; and m represents an integer of 0-5] have exceptional bromodomain inhibitory activity and are useful as treatment agents for the prevention and/or treatment of tumors involving bromodomains.
Patent CA-3050755-A1 (CA)
Title: Mesh material for flexible structures and methods of fabricating same
Inventor: CHEN HAO
IPC: A01M31/02
Filed: 2019-07-26
Abstract: A mesh material for fabricating hunting blinds, tents, and other similar flexible structures. The material is durable, water-resistant, and partially light-transmissive such that persons or objects inside or behind the structures are not easily seen from outside the structures. The material is also semi-permeable to air flow for ventilation purposes. The mesh material is fabricated from an interwoven polyester fabric that is coated with acrylic and a mixture of silicone and ethylene vinyl acetate (EVA). Patterns and/or colors are printed on both sides of the fabric with a heat transfer paper printing process to provide a desired level of light transmissivity.
Patent CA-3057691-A1 (CA)
Inventor: TSCHOL ARMIN
IPC: A46B9/04
Filed: 2018-03-29
Abstract: L'invention concerne une tête pour un instrument de soins buccaux présentant une surface de montage comprenant au moins une touffe d'une première longueur et au moins une touffe d'une seconde longueur, la première longueur étant plus longue que la seconde longueur mesurée à partir de la surface de montage de la tête le long d'un axe longitudinal des touffes. Ladite touffe de la première longueur comprend des filaments ayant une zone de section transversale sensiblement circulaire s'étendant dans un plan perpendiculaire à l'axe longitudinal et une extrémité libre arrondie en bout, tandis que ladite touffe de la seconde longueur comprend des filaments marqués ayant des extrémités libres fendues.
Patent CA-3059765-A1 (CA)
Inventor: POLLAK MICHAEL
IPC: G06F3/048
Filed: 2018-04-10
Abstract: Un système de recherche est utilisé pour présenter, à un utilisateur du système de recherche, des diamants qui sont disponibles à la vente. Le système de recherche comprend une interface graphique au moyen de laquelle l'utilisateur peut entrer des paramètres de recherche correspondant à des caractéristiques gémmologiques. Des listes de diamants sont générées en fonction des paramètres de recherche et établies en fonction des préférences de l'utilisateur.
Patent CA-3062165-A1 (CA)
Inventor: ZHAO YANGBING
IPC: C12N9/00
Filed: 2018-05-02
Abstract: The present invention includes compositions and methods for modifying primary T cells. In one aspect, the invention comprises administering to a cell a stem-loop Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) RNA (st-crRNA) and a Cpf1 enzyme.
Patent CA-3063322-A1 (CA)
Title: Enhanced solubility drug-containing formulations
Inventor: HURREY MICHAEL LAIRD
IPC: A61K47/12
Filed: 2018-05-10
Abstract: This invention describes compositions comprising at least 75 mg/m L of solubilized otherwise poorly soluble drug in an aqueous environment, wherein the composition further comprises a combination of 3 or more acids. Methods of providing analgesia, anti- pyretic effects or reducing pain in a subject presenting with a pain condition, and methods of reducing administration site irritation, inflammation or a combination thereof in a subject presenting with a pain condition, comprising the steps of administering such compositions and infusion pumps containing such compositions are also described.
Patent CA-3063758-A1 (CA)
Title: Low profile transcatheter heart valve
Inventor: HARITOU LLIA
IPC: A61F2/958
Filed: 2019-04-29
Abstract: An implantable prosthetic valve (10), according to one embodiment, comprises a frame (12), a leaflet structure (14), and a skirt member (16). The frame can have a plurality of axial struts (20) interconnected by a plurality of circumferential struts (22, 24). The leaflet structure comprises a plurality of leaflets (e.g., three leaflets arrange to form a tricuspid valve). The leaflet structure has a scalloped lower edge portion secured to the frame. The skirt member can be disposed between the leaflet structure and the frame.
Patent CA-3065188-A1 (CA)
Title: Egg-free simulated egg food products
Inventor: LEWIS DEBORAH ANN
IPC: A23L15/00
Filed: 2018-05-31
Abstract: Disclosed herein is a composition for producing egg-free simulated egg food products. The composition comprises whey protein, a soy material comprising a lipoxygenase inactivated soy flour and a pH modifying agent effective to alkalinise the composition upon hydration. A simulated egg food product having organoleptic properties similar to those of the egg food product if produced using hen eggs is produced upon hydrating and then cooking the composition.
Patent CA-3071417-A1 (CA)
Inventor: CHEN XIN
IPC: B61L23/04
Filed: 2018-07-27
Abstract: A method for inspecting a railroad track include detecting, using one or more sensors of an inspection system, movement of a transport device along the railroad track, responsive to the detecting, automatically actuating one or more cameras of the inspection system, receiving, from at least one of the one or more cameras, first image data reproducible as a first image of a first portion of the railroad track, analyzing the first image data to identify the presence or absence of one or more features of interest on the first portion of the railroad track; determining a first location of the transport device, and associating the first location of the transport device with the first image data.
Patent CA-3071481-A1 (CA)
Inventor: BOUCHOOU JEANNE
IPC: E04B1/10
Filed: 2018-08-03
Abstract: The present invention relates to a construction element (10) with superposed wooden structural boards (101, 111). The boards are provided with grooved patterns (R101A, R111B) at the contact interface (I101-111) between the boards in order to prevent the first board (101) and the second board (111) from sliding relative to each other along at least one axis. The construction element (10) further comprises a retention system (30) for retaining the boards (101, 111) against each other at the contact interface (I101-111). According to the present invention, the grooved patterns (R101A, R111B) are pre-pressed against each other and the retention system (30) comprises at least one metal threaded rod component (30.1, 30.2) at least partially passing through at least two of the wooden structural boards (101, 111) at the contact interface (I101-111).
Patent CA-3072353-A1 (CA)
Title: Nouveaux inhibiteurs d'usp7 pour le traitement du myelome multiple
Inventor: BUHRLAGE SARA
IPC: A61K31/44
Filed: 2018-09-26
Abstract: La présente invention concerne des inhibiteurs d'USP7 utiles dans le traitement de maladies médiées par USP7 et d'autres maladies, ayant la formule : R1, R2, R3, R4, R5, R 6, et n étant décrits dans la description.
Patent CA-3074759-A1 (CA)
Title: M-diamide compound and preparation method therefor and use thereof
Inventor: LV LIANG
IPC: A01N37/18
Filed: 2019-03-12
Abstract: Provided are m-diamide compounds and a preparation method therefor and the use thereof. The m-diamide compounds have a structure represented by formula I. The m-diamide compounds of the present invention can have a high insecticidal activity at a low dose and take effect rapidly, can exert the insecticidal activity one day after application, can achieve a high insecticidal activity within three days, and have a good fast-acting property; moreover, due to the good effect at a low dose, the m-diamide compounds can reduce the damage to plants and human beings caused by excessive drug concentrations, enable less drug residue to be generated during application which is more conducive to environmental protection, and have broad application prospects.
Patent CA-3076359-A1 (CA)
Title: Microbiome health index
Inventor: BLOUNT KENNETH F
IPC: C12Q1/689
Filed: 2018-10-12
Abstract: Methods for assessing microbiota are disclosed. An example method for assessing microbiota may include obtaining a fecal sample from a patient, quantifying the relative abundance of bacteria from a selected group of taxonomic classes in the fecal sample, calculating a microbiome health index based on the relative abundance of bacteria from the selected group of taxonomic classes, and correlating the microbiome health index with a medical condition of the patient.
Patent CA-3078039-A1 (CA)
Inventor: REDFORD TIMOTHY
IPC: F02C9/18
Filed: 2020-04-14
Abstract: The aircraft engine can have a core gas path extending from an intake across a core compressor, and then manifolding to a plurality turbine intake paths, each turbine intake path leading to a respective turbine unit via a respective combustor unit, and gearing drivingly connecting the collective rotary power of the turbine units to at least one power output shaft. During operation, the different core-turbine units can be operated simultaneously and efficiently, or one or more of the core-turbine units can be selectively shut down while the other core-turbine units continue to operate efficiently to lower the power output.
Patent CA-3085233-A1 (CA)
Inventor: J S KNUTSEN LARS
IPC: A61P21/04
Filed: 2018-12-14
Abstract: The present invention relates to compounds suitable for treating, ameliorating and/or preventing neuromuscular disorders, including the reversal of drug-induced neuromuscular blockade. The compounds as defined herein preferably inhibit the ClC-1 ion channel.
Patent CA-3090111-A1 (CA)
Title: Waste disposer
Inventor: WANG WEI
IPC: B65F1/00
Filed: 2020-08-14
Abstract: A waste disposer comprising a primary dehydrating chamber, a grinding device, a secondary dehydrating chamber, and a storage chamber. The primary dehydrating chamber is adapted to allow waste to be heated therein to partly dehydrate the waste.  The primary dehydrating chamber has: a first waste inlet for receiving the waste, a first vapor outlet for exhausting vapor from the waste, a drainage outlet for draining free liquid from the waste, and a first waste outlet for outputting the partly dehydrated waste. The grinding device is adapted to receive the waste from the first waste outlet and grind the waste to reduce the size thereof The secondary dehydrating chamber is adapted to allow the ground waste to be heated therein to further dehydrate the waste. The secondary dehydrating chamber has a second waste inlet for receiving the ground waste, a second vapor outlet for exhausting vapor from the waste, and a second waste outlet for outputting the further dehydrated waste. The storage chamber is adapted to receive the waste from the second waste outlet and store the waste in the storage chamber.
Patent CA-3091163-A1 (CA)
Title: A method and material for isolating a severe loss zone
Inventor: AMANULLAH MD
IPC: E21B33/138
Filed: 2019-02-13
Abstract: A method and drilling fluid additive for reducing severe fluid losses in a well, comprising a combination of granular scrap tire particles and polymer adhesive molded into a capsule shape. Once in the severe loss zone, a plurality of LCMs wedge into the formation fractures and seal off the severe loss zone.
Patent CA-3091209-A1 (CA)
Inventor: PORGES STEPHEN
IPC: A61B5/02
Filed: 2019-03-01
Abstract: Methods and systems are provided to monitor bio-signals associated with one or more physiological structures of a subject, process the bio-signals to determine neural information, determine a current state of the subject based on the neural information, determine feedback to be provided to the subject based on the current state and a desired state, and/or to provide the feedback to the subject in order to modify the subject's current state to the desired state. The neural information may include validated neural indices relating to dynamic regulation of the monitored physiological structures via identifiable neural pathways and/or neural metrics quantified from such neural indices.
Patent CA-3093680-A1 (CA)
Inventor: GRAY MARK EDWARD
IPC: G10L15/00
Filed: 2019-03-05
Abstract: A system for providing help includes at least one digital assistant and a wireless data interface for connecting the digital assistants to a server. A plurality of agent computers is connected to the server by a data network. Each of the at least one digital assistants is preprogrammed and centrally managed with at least one skill for recognizing a preprogrammed specific utterance and each of the at least one digital assistants is pre-configured to connect with the wireless data interface. After the preprogrammed specific utterance is detected by one of the digital assistants, that digital assistant initiates a request for help to the server and upon receiving the request for the help, the server assigns one of the agent computers and forwards the request for help to the one of the agent computers.
Patent CA-3093819-A1 (CA)
Inventor: FERRO FLORES GUILLERMINA
IPC: A61P35/00
Filed: 2019-03-07
Abstract: The invention relates to a new lutetium-177 therapeutic radiopharmaceutical as an inhibitor of prostate-specific membrane antigen (iPSMA), wherein 1,4,7,10-tetraazacyclododecane-N,N´,N´´,N´´´´-tetraacetic acid (DOTA) bonded to the heterocyclic molecule hydrazinonicotinamide (HYNIC), generates a rigid chemical structure that minimises the number of conformers and intramolecular hydrogen bonds, thereby producing a favourable spatial orientation of the active site (Lys(Nal)-NH-CO-NH-Glu) in the molecule, for biological recognition by the PSMA protein. The new 177Lu-DOTA-HYNIC-iPSMA radiopharmaceutical accumulates, with high affinity in vivo, in tumours that overexpress the PSMA protein, acting as a radiotherapeutic agent. The purpose of the invention is to provide a new specific radiopharmaceutical (molecular target radiopharmaceutical) for the treatment of tumours with PSMA overexpression.
Patent CA-3096014-A1 (CA)
Title: Tension-free titanium metal knitted fabric for surgically shaping soft tissues
Inventor: Kazantsev Anton Anatolevich
IPC: A61L27/06
Filed: 2018-03-01
Abstract: The invention relates to the fields of medicine and medical technology and is directed toward improving the technical properties of mesh implants used for delicately surgically shaping thin anatomical structures: eyelids, cornea, etc. A  tension-free titanium metal warp knit fabric for surgically shaping soft tissues is a mesh fabric made of titanium threads bent to form interconnected loops, wherein the titanium threads have a contoured surface. The technical result is a decrease in the elasticity and an increase in the plasticity of the material, making it possible to incorporate said material into thin anatomical structures without risk of trauma, while improving the formation of connective tissue, reducing wound discharge, shortening healing times, and reducing the rate of complications, thus enabling more rapid recovery of patients.
Patent CA-3100153-A1 (CA)
Inventor: BATARSEH SAMEEH ISSA
IPC: E21B7/14
Filed: 2018-09-28
Abstract: An example laser tool (30) is configured to operate within a wellbore (4) of a hydrocarbon-bearing rock formation. The tool (30) includes one or more optical transmission media (20). The one or more optical transmission media (20) are part of an optical path originating at a laser generator (10) configured to generate a laser beam (160). The tool (30) includes a mono-optic element (105) that is part of the optical path. The mono-optic element (105) is for receiving the laser beam from the one or more optical transmission media (20) and for altering at least one of a geometry or a direction of the laser beam for output to the hydrocarbon-bearing rock formation. The tool (30) also includes one or more sensors (340) to monitor one or more conditions in the wellbore and to output signals based on the one or more conditions.